Gary Gordon

12.2k citations
109 papers · 10.3k · 4 hit papers · h-index 41

Impact in

  • Pharmacology top 0.2%
    • Inflammatory mediators and NSAID effects
  • Genetics top 0.5%
    • Chronic Lymphocytic Leukemia Research
    • Estrogen and related hormone effects

Papers in

Gary Gordon

101 papers receiving 9.8k citations

Gary Gordon's Hit Papers

Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma 2017 · 621 citations
6210+8+17Years since publication50010001.5k2.0k

Peers

Gary Gordon
Comparison fields: 5 of 151
  • Pharmacology 2.2k
  • Genetics 1.4k
  • Pathology and Forensic Medicine 1.8k
  • Oncology 2.3k
  • Cancer Research 1.1k
Replace Chisato Miyaura with:
Chisato Miyaura Japan
Matthew M. Ames United States
Ron H. J. Mathijssen Netherlands
Daniel D. Karp United States
Monica M. Bertagnolli United States
Walter N. Hittelman United States
Daniel Paul Normolle United States
Min‐Liang Kuo Taiwan
Ari Ristimäki Finland
George F. Schreiner United States
Gary Gordon relative to Chisato Miyaura Japan Chisato Miyaura's profile →
Citations per field
00.5×2×4×6×7.0×
Chisato Miyaura · 1×
Citations per year

Countries citing papers authored by Gary Gordon

Since Specialization
Citations

This map shows the geographic impact of Gary Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Gordon more than expected).

Fields of papers citing papers by Gary Gordon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Gordon. The network helps show where Gary Gordon may publish in the future.

Co-authors

The 25 scholars most cited alongside Gary Gordon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gary Gordon Line = papers co-authored together Gary Gordon links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Hit paper breakdown →
20002146
2
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
Hit paper breakdown →
2006900
3
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study
Hit paper breakdown →
2016686
4
Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Hit paper breakdown →
2017621
5 1999367
6
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.
2002318
7 2017279
8 2009267
9 2018259
10
Distinguishing right from left colon by the pattern of gene expression.
2003238
11 1988213
12 1981205
13 2010204
14 2004201
15 2001175
16
Soy, its components, and cancer prevention: a review of the in vitro, animal, and human data.
1998166
17 1987145
18 1981137
19 1990133
20 1991133

About Gary Gordon

Gary Gordon is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism, Oncology, Pharmacology and Pharmacology, having authored 109 papers that have together received 10.3k indexed citations. Recurring topics across this work include Hormonal and reproductive studies (10 papers), Inflammatory mediators and NSAID effects (9 papers), Hormonal Regulation and Hypertension (7 papers), Estrogen and related hormone effects (6 papers), Cancer Treatment and Pharmacology (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Microfluidic and Capillary Electrophoresis Applications (5 papers). The work is most often cited by research in Pharmacology (2.2k citations), Genetics (1.4k citations), Pathology and Forensic Medicine (1.8k citations), Oncology (2.3k citations) and Cancer Research (1.1k citations). Gary Gordon has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include David B. Fournier, Stephen P. Spielberg, David A. Blake, Yuesheng Zhang, Harlan F. Weisman, Lisa M. Shantz, Paul Talalay, David E A Bush, Gary J. Kelloff and Claudio Jorge Conti. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, Neuro-Oncology and Journal of Cellular Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact